Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 239

1.

A prospective study of aspirin use and prostate cancer risk by TMPRSS2:ERG status.

Stopsack KH, Gonzalez-Feliciano AG, Peisch SF, Downer MK, Gage RA, Finn S, Lis RT, Graff RE, Pettersson A, Pernar CH, Loda M, Kantoff PW, Ahearn TU, Mucci LA.

Cancer Epidemiol Biomarkers Prev. 2018 Aug 14. pii: cebp.0510.2018. doi: 10.1158/1055-9965.EPI-18-0510. [Epub ahead of print]

PMID:
30108097
2.

Family history of breast or prostate cancer and prostate cancer risk.

Barber LE, Gerke T, Markt SC, Peisch SF, Wilson KM, Ahearn TU, Giovannucci EL, Parmigiani G, Mucci LA.

Clin Cancer Res. 2018 Aug 6. pii: clincanres.0370.2018. doi: 10.1158/1078-0432.CCR-18-0370. [Epub ahead of print]

PMID:
30082473
3.

Corpora amylacea in prostatectomy tissue and associations with molecular, histological, and lifestyle factors.

DuPre NC, Flavin R, Sfanos KS, Unger RH, To S, Gazeeva E, Fiorentino M, De Marzo AM, Rider JR, Mucci LA; Transdisciplinary Prostate Cancer Partnership(ToPCaP).

Prostate. 2018 Jul 15. doi: 10.1002/pros.23692. [Epub ahead of print]

PMID:
30009541
4.

Regular aspirin use and gene expression profiles in prostate cancer patients.

Stopsack KH, Ebot EM, Downer MK, Gerke TA, Rider JR, Kantoff PW, Mucci LA.

Cancer Causes Control. 2018 Jun 18. doi: 10.1007/s10552-018-1049-5. [Epub ahead of print]

PMID:
29915914
5.

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, Tyrer J, Muir K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman PJ, Thompson IM Jr, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger GP, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Håkansson N, West CML, Dunning AM, Burnet N, Mucci LA, Giovannucci E, Andriole GL, Cussenot O, Cancel-Tassin G, Koutros S, Beane Freeman LE, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein BS, Kerns SL, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, Røder MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Singhal S, Slavov C, Mitev V, Parliament M, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Dominguez MG, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA; Profile Study, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Cui Z, Kraft P; Australian Prostate Cancer BioResource (APCB); IMPACT Study; Canary PASS Investigators; Breast and Prostate Cancer Cohort Consortium (BPC3); PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium; Cancer of the Prostate in Sweden (CAPS); Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS); Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium, Amos CI, Conti DV, Easton DF, Wiklund F, Chanock SJ, Henderson BE, Kote-Jarai Z, Haiman CA, Eeles RA.

Nat Genet. 2018 Jul;50(7):928-936. doi: 10.1038/s41588-018-0142-8. Epub 2018 Jun 11.

PMID:
29892016
6.

ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D.

Komura K, Yoshikawa Y, Shimamura T, Chakraborty G, Gerke TA, Hinohara K, Chadalavada K, Jeong SH, Armenia J, Du SY, Mazzu YZ, Taniguchi K, Ibuki N, Meyer CA, Nanjangud GJ, Inamoto T, Lee GM, Mucci LA, Azuma H, Sweeney CJ, Kantoff PW.

J Clin Invest. 2018 Jul 2;128(7):2979-2995. doi: 10.1172/JCI96769. Epub 2018 Jun 4.

7.

Differential Gene Expression in Prostate Tissue According to Ejaculation Frequency.

Sinnott JA, Brumberg K, Wilson KM, Ebot EM, Giovannucci EL, Mucci LA, Rider JR.

Eur Urol. 2018 May 18. pii: S0302-2838(18)30353-1. doi: 10.1016/j.eururo.2018.05.006. [Epub ahead of print]

PMID:
29784192
8.

Dietary Acrylamide Intake and Risk of Renal Cell Carcinoma in Two Large Prospective Cohorts.

Graff RE, Cho E, Preston MA, Sanchez A, Mucci LA, Wilson KM.

Cancer Epidemiol Biomarkers Prev. 2018 Aug;27(8):979-982. doi: 10.1158/1055-9965.EPI-18-0320. Epub 2018 May 14.

PMID:
29760239
9.

Liver Disease in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer.

Gild P, Cole AP, Krasnova A, Dickerman BA, von Landenberg N, Sun M, Mucci LA, Lipsitz SR, Chun FK, Nguyen PL, Kibel AS, Choueiri TK, Basaria S, Trinh QD.

J Urol. 2018 Apr 16. pii: S0022-5347(18)42984-9. doi: 10.1016/j.juro.2018.03.135. [Epub ahead of print]

PMID:
29673944
10.

Geographic Differences in Baseline Prostate Inflammation and Relationship with Subsequent Prostate Cancer Risk: Results from the Multinational REDUCE Trial.

Allott EH, Markt SC, Howard LE, Vidal AC, Moreira DM, Castro-Santamaria R, Andriole GL, Mucci LA, Freedland SJ.

Cancer Epidemiol Biomarkers Prev. 2018 Jul;27(7):783-789. doi: 10.1158/1055-9965.EPI-18-0076. Epub 2018 Apr 18.

PMID:
29669727
11.

Cognitive Impairment in Men with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis.

Sun M, Cole AP, Hanna N, Mucci LA, Berry DL, Basaria S, Ahern DK, Kibel AS, Choueiri TK, Trinh QD.

J Urol. 2018 Jun;199(6):1417-1425. doi: 10.1016/j.juro.2017.11.136. Epub 2018 Feb 2. Review.

PMID:
29410294
12.

Reply.

Graff RE, Mucci LA, Hjelmborg JB.

Clin Gastroenterol Hepatol. 2018 Feb;16(2):298-299. doi: 10.1016/j.cgh.2017.09.018. No abstract available.

PMID:
29389490
13.

The Epidemiology of Prostate Cancer.

Pernar CH, Ebot EM, Wilson KM, Mucci LA.

Cold Spring Harb Perspect Med. 2018 Jan 8. pii: a030361. doi: 10.1101/cshperspect.a030361. [Epub ahead of print]

PMID:
29311132
14.

Height, Obesity, and the Risk of TMPRSS2:ERG-Defined Prostate Cancer.

Graff RE, Ahearn TU, Pettersson A, Ebot EM, Gerke T, Penney KL, Wilson KM, Markt SC, Pernar CH, Gonzalez-Feliciano AG, Song M, Lis RT, Schmidt DR, Vander Heiden MG, Fiorentino M, Giovannucci EL, Loda M, Mucci LA.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):193-200. doi: 10.1158/1055-9965.EPI-17-0547. Epub 2017 Nov 22.

PMID:
29167279
15.

Current or recent smoking is associated with more variable telomere length in prostate stromal cells and prostate cancer cells.

Joshu CE, Peskoe SB, Heaphy CM, Kenfield SA, Mucci LA, Giovannucci EL, Stampfer MJ, Yoon G, Lee TK, Hicks JL, De Marzo AM, Meeker AK, Platz EA.

Prostate. 2018 Feb;78(3):233-238. doi: 10.1002/pros.23462. Epub 2017 Nov 22.

PMID:
29164645
16.

MYC Overexpression at the Protein and mRNA Level and Cancer Outcomes among Men Treated with Radical Prostatectomy for Prostate Cancer.

Pettersson A, Gerke T, Penney KL, Lis RT, Stack EC, Pértega-Gomes N, Zadra G, Tyekucheva S, Giovannucci EL, Mucci LA, Loda M.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):201-207. doi: 10.1158/1055-9965.EPI-17-0637. Epub 2017 Nov 15.

17.

Midlife metabolic factors and prostate cancer risk in later life.

Dickerman BA, Torfadottir JE, Valdimarsdottir UA, Wilson KM, Steingrimsdottir L, Aspelund T, Batista JL, Fall K, Giovannucci E, Sigurdardottir LG, Tryggvadottir L, Gudnason V, Markt SC, Mucci LA.

Int J Cancer. 2018 Mar 15;142(6):1166-1173. doi: 10.1002/ijc.31142. Epub 2017 Nov 16.

PMID:
29114858
18.

Lung cancer, genetic predisposition and smoking: the Nordic Twin Study of Cancer.

Hjelmborg J, Korhonen T, Holst K, Skytthe A, Pukkala E, Kutschke J, Harris JR, Mucci LA, Christensen K, Czene K, Adami HO, Scheike T, Kaprio J; Nordic Twin Study of Cancer (NorTwinCan) collaboration.

Thorax. 2017 Nov;72(11):1021-1027. doi: 10.1136/thoraxjnl-2015-207921. Epub 2016 Nov 14.

PMID:
29054888
19.

Expression and Genetic Variation in Neuroendocrine Signaling Pathways in Lethal and Nonlethal Prostate Cancer among Men Diagnosed with Localized Disease.

Lu D, Carlsson J, Penney KL, Davidsson S, Andersson SO, Mucci LA, Valdimarsdóttir U, Andrén O, Fang F, Fall K.

Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1781-1787. doi: 10.1158/1055-9965.EPI-17-0453. Epub 2017 Sep 22.

PMID:
28939587
20.

Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer.

Tyekucheva S, Bowden M, Bango C, Giunchi F, Huang Y, Zhou C, Bondi A, Lis R, Van Hemelrijck M, Andrén O, Andersson SO, Watson RW, Pennington S, Finn SP, Martin NE, Stampfer MJ, Parmigiani G, Penney KL, Fiorentino M, Mucci LA, Loda M.

Nat Commun. 2017 Sep 4;8(1):420. doi: 10.1038/s41467-017-00460-4.

21.

Is the Evidence Sufficient to Recommend Statins for All Men With Prostate Cancer?

Mucci LA, Kantoff PW.

J Clin Oncol. 2017 Oct 10;35(29):3272-3274. doi: 10.1200/JCO.2017.74.7915. Epub 2017 Aug 17. No abstract available.

PMID:
28817369
22.

Heritability of the Number of Teeth in Middle-Aged and Older Danish Twins.

Kurushima Y, Silventoinen K, Dokkedal U, Skytthe A, Mucci LA, Christensen K, Hjelmborg JVB.

J Dent Res. 2017 Dec;96(13):1513-1517. doi: 10.1177/0022034517724782. Epub 2017 Aug 8.

PMID:
28787219
23.

The impact of statin use on the efficacy of abiraterone acetate in patients with castration-resistant prostate cancer.

Harshman LC, Werner L, Tripathi A, Wang X, Maughan BL, Antonarakis ES, Nakabayashi M, McKay R, Pomerantz M, Mucci LA, Taplin ME, Sweeney CJ, Lee GM, Kantoff PW.

Prostate. 2017 May;77(13):1303-1311. doi: 10.1002/pros.23390. Epub 2017 Aug 1.

24.

Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.

Pergolini I, Sahora K, Ferrone CR, Morales-Oyarvide V, Wolpin BM, Mucci LA, Brugge WR, Mino-Kenudson M, Patino M, Sahani DV, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C.

Gastroenterology. 2017 Nov;153(5):1284-1294.e1. doi: 10.1053/j.gastro.2017.07.019. Epub 2017 Jul 21.

PMID:
28739282
25.

Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer.

Ebot EM, Gerke T, Labbé DP, Sinnott JA, Zadra G, Rider JR, Tyekucheva S, Wilson KM, Kelly RS, Shui IM, Loda M, Kantoff PW, Finn S, Vander Heiden MG, Brown M, Giovannucci EL, Mucci LA.

Cancer. 2017 Nov 1;123(21):4130-4138. doi: 10.1002/cncr.30831. Epub 2017 Jul 12.

PMID:
28700821
26.

A Walking Intervention Among Men With Prostate Cancer: A Pilot Study.

Pernar CH, Fall K, Rider JR, Markt SC, Adami HO, Andersson SO, Valdimarsdottir U, Andrén O, Mucci LA.

Clin Genitourin Cancer. 2017 Dec;15(6):e1021-e1028. doi: 10.1016/j.clgc.2017.05.022. Epub 2017 May 31.

PMID:
28668276
27.

Authors' reply to Rishniw.

Markt SC, Mucci LA.

BMJ. 2017 Jun 16;357:j2910. doi: 10.1136/bmj.j2910. No abstract available.

PMID:
28623236
28.

Cholesterol uptake and regulation in high-grade and lethal prostate cancers.

Stopsack KH, Gerke TA, Andrén O, Andersson SO, Giovannucci EL, Mucci LA, Rider JR.

Carcinogenesis. 2017 Aug 1;38(8):806-811. doi: 10.1093/carcin/bgx058.

29.

Prostate cancer incidence as an iceberg.

Mucci LA, Pernar CH, Peisch S, Gerke T, Wilson KM.

Eur J Epidemiol. 2017 Jun;32(6):477-479. doi: 10.1007/s10654-017-0265-8. Epub 2017 May 30. No abstract available.

30.

Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer.

Dickerman BA, Ahearn TU, Giovannucci E, Stampfer MJ, Nguyen PL, Mucci LA, Wilson KM.

Int J Cancer. 2017 Sep 1;141(5):933-944. doi: 10.1002/ijc.30803. Epub 2017 Jun 8.

PMID:
28543830
31.

Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health Study.

Downer MK, Allard CB, Preston MA, Gaziano JM, Stampfer MJ, Mucci LA, Batista JL.

Eur Urol. 2017 Nov;72(5):821-827. doi: 10.1016/j.eururo.2017.01.044. Epub 2017 Feb 8.

PMID:
28189429
32.

Dairy intake in relation to prostate cancer survival.

Downer MK, Batista JL, Mucci LA, Stampfer MJ, Epstein MM, Håkansson N, Wolk A, Johansson JE, Andrén O, Fall K, Andersson SO.

Int J Cancer. 2017 May 1;140(9):2060-2069. doi: 10.1002/ijc.30642. Epub 2017 Feb 22.

33.

The ABC model of prostate cancer: A conceptual framework for the design and interpretation of prognostic studies.

Pettersson A, Gerke T, Fall K, Pawitan Y, Holmberg L, Giovannucci EL, Kantoff PW, Adami HO, Rider JR, Mucci LA; Transdisciplinary Prostate Cancer Partnership (ToPCaP).

Cancer. 2017 May 1;123(9):1490-1496. doi: 10.1002/cncr.30582. Epub 2017 Feb 2. Review.

34.

Familial Risk and Heritability of Colorectal Cancer in the Nordic Twin Study of Cancer.

Graff RE, Möller S, Passarelli MN, Witte JS, Skytthe A, Christensen K, Tan Q, Adami HO, Czene K, Harris JR, Pukkala E, Kaprio J, Giovannucci EL, Mucci LA, Hjelmborg JB.

Clin Gastroenterol Hepatol. 2017 Aug;15(8):1256-1264. doi: 10.1016/j.cgh.2016.12.041. Epub 2017 Jan 24.

35.

Re: Won Sik Ham, Heather J. Chalfin, Zhaoyong Feng, et al. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer. Eur Urol 2017;71:907-12.

Fankhauser CD, Mucci LA, Gerke TA.

Eur Urol. 2017 Jul;72(1):e9-e10. doi: 10.1016/j.eururo.2017.01.016. Epub 2017 Jan 17. No abstract available.

36.

Circulating Antioxidant Levels and Risk of Prostate Cancer by TMPRSS2:ERG.

Graff RE, Judson G, Ahearn TU, Fiorentino M, Loda M, Giovannucci EL, Mucci LA, Pettersson A.

Prostate. 2017 May;77(6):647-653. doi: 10.1002/pros.23312. Epub 2017 Jan 19.

37.

Perineural Invasion and Risk of Lethal Prostate Cancer.

Zareba P, Flavin R, Isikbay M, Rider JR, Gerke TA, Finn S, Pettersson A, Giunchi F, Unger RH, Tinianow AM, Andersson SO, Andrén O, Fall K, Fiorentino M, Mucci LA; Transdisciplinary Prostate Cancer Partnership (ToPCaP).

Cancer Epidemiol Biomarkers Prev. 2017 May;26(5):719-726. doi: 10.1158/1055-9965.EPI-16-0237. Epub 2017 Jan 6.

38.

The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study.

Kelly RS, Sinnott JA, Rider JR, Ebot EM, Gerke T, Bowden M, Pettersson A, Loda M, Sesso HD, Kantoff PW, Martin NE, Giovannucci EL, Tyekucheva S, Heiden MV, Mucci LA.

Cancer Metab. 2016 Dec 7;4:22. doi: 10.1186/s40170-016-0161-9. eCollection 2016.

39.

Sniffing out significant "Pee values": genome wide association study of asparagus anosmia.

Markt SC, Nuttall E, Turman C, Sinnott J, Rimm EB, Ecsedy E, Unger RH, Fall K, Finn S, Jensen MK, Rider JR, Kraft P, Mucci LA.

BMJ. 2016 Dec 13;355:i6071. doi: 10.1136/bmj.i6071.

40.

Early Life Residence, Fish Consumption, and Risk of Breast Cancer.

Haraldsdottir A, Steingrimsdottir L, Valdimarsdottir UA, Aspelund T, Tryggvadottir L, Harris TB, Launer LJ, Mucci LA, Giovannucci EL, Adami HO, Gudnason V, Torfadottir JE.

Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):346-354. doi: 10.1158/1055-9965.EPI-16-0473-T. Epub 2016 Oct 10.

41.

Sleep disruption, chronotype, shift work, and prostate cancer risk and mortality: a 30-year prospective cohort study of Finnish twins.

Dickerman BA, Markt SC, Koskenvuo M, Hublin C, Pukkala E, Mucci LA, Kaprio J.

Cancer Causes Control. 2016 Nov;27(11):1361-1370. Epub 2016 Oct 12.

42.

Prognostic Utility of a New mRNA Expression Signature of Gleason Score.

Sinnott JA, Peisch SF, Tyekucheva S, Gerke T, Lis R, Rider JR, Fiorentino M, Stampfer MJ, Mucci LA, Loda M, Penney KL.

Clin Cancer Res. 2017 Jan 1;23(1):81-87. doi: 10.1158/1078-0432.CCR-16-1245. Epub 2016 Sep 23.

43.

Meat, Fish, Poultry, and Egg Intake at Diagnosis and Risk of Prostate Cancer Progression.

Wilson KM, Mucci LA, Drake BF, Preston MA, Stampfer MJ, Giovannucci E, Kibel AS.

Cancer Prev Res (Phila). 2016 Dec;9(12):933-941. Epub 2016 Sep 20.

44.

Snus use, smoking and survival among prostate cancer patients.

Wilson KM, Markt SC, Fang F, Nordenvall C, Rider JR, Ye W, Adami HO, Stattin P, Nyrén O, Mucci LA.

Int J Cancer. 2016 Dec 15;139(12):2753-2759. doi: 10.1002/ijc.30411.

45.

Common medications and prostate cancer mortality: a review.

Stopsack KH, Greenberg AJ, Mucci LA.

World J Urol. 2017 Jun;35(6):875-882. doi: 10.1007/s00345-016-1912-5. Epub 2016 Aug 4. Review.

PMID:
27492013
46.

Pineal Gland Volume Assessed by MRI and Its Correlation with 6-Sulfatoxymelatonin Levels among Older Men.

Sigurdardottir LG, Markt SC, Sigurdsson S, Aspelund T, Fall K, Schernhammer E, Rider JR, Launer L, Harris T, Stampfer MJ, Gudnason V, Czeisler CA, Lockley SW, Valdimarsdottir UA, Mucci LA.

J Biol Rhythms. 2016 Oct;31(5):461-9. doi: 10.1177/0748730416656948. Epub 2016 Jul 22.

47.

CHALLENGE Trial 1 Year Feasibility Results-Letter.

Pernar CH, Markt SC, McKay RR, Mucci LA.

Cancer Epidemiol Biomarkers Prev. 2016 Aug;25(8):1277. doi: 10.1158/1055-9965.EPI-16-0393. Epub 2016 Jul 14. No abstract available.

48.

Total antioxidant intake and prostate cancer in the Cancer of the Prostate in Sweden (CAPS) study. A case control study.

Russnes KM, Möller E, Wilson KM, Carlsen M, Blomhoff R, Smeland S, Adami HO, Grönberg H, Mucci LA, Bälter K.

BMC Cancer. 2016 Jul 11;16:438. doi: 10.1186/s12885-016-2486-8.

49.

Vascular morphology differentiates prostate cancer mortality risk among men with higher Gleason grade.

Yang M, Zu K, Mucci LA, Rider JR, Fiorentino M, Clinton SK, Loda M, Stampfer MJ, Giovannucci E.

Cancer Causes Control. 2016 Aug;27(8):1043-7. doi: 10.1007/s10552-016-0782-x. Epub 2016 Jul 5.

50.

Alcohol intake, drinking patterns, and prostate cancer risk and mortality: a 30-year prospective cohort study of Finnish twins.

Dickerman BA, Markt SC, Koskenvuo M, Pukkala E, Mucci LA, Kaprio J.

Cancer Causes Control. 2016 Sep;27(9):1049-58. doi: 10.1007/s10552-016-0778-6. Epub 2016 Jun 28.

Supplemental Content

Loading ...
Support Center